drugset / Trial / NCT00712686

Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia

NCT00712686

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the efficacy and tolerability of aripiprazole to olanzapine over 26 weeks for the treatment of schizophrenia

Timeline

Start
2000-06
Primary completion
2003-12
Completion
2003-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aripiprazole Other / unclassified 15 mg Oral
Comparator Aripiprazole Other / unclassified 30 mg Oral
Comparator Olanzapine Small molecule 10 mg Oral
Comparator Olanzapine Small molecule 20 mg Oral

Indications